SecSonar.com

Pulse Biosciences, Inc. (PLSE)

Pulse Biosciences, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Pulse Biosciences, Inc. (PLSE) is a Medical - Instruments & Supplies company based in US with a market capitalization of $1.8B. Free cash flow was negative at -$54.4M. This page tracks PLSE's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 75 employees · IPO May 18, 2016

Valuation

Valuation & price

$24.55 · as of May 17, 2026 · -16.0% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

21.84

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$28.45$20.55$12.66Jul 25Dec 25Jul 26Jul 7, 25$15.81Jul 9, 25$16.19Jul 11, 25$16.03Jul 15, 25$15.22Jul 17, 25$15.65Jul 21, 25$14.97Jul 23, 25$15.17Jul 25, 25$14.93Jul 29, 25$14.71Jul 31, 25$15.02Aug 4, 25$15.07Aug 6, 25$15.34Aug 11, 25$14.88Aug 13, 25$16.79Aug 15, 25$16.16Aug 19, 25$15.86Aug 21, 25$16.00Aug 25, 25$16.49Aug 27, 25$15.85Aug 29, 25$15.54Sep 3, 25$14.99Sep 5, 25$15.11Sep 9, 25$14.94Sep 11, 25$15.10Sep 16, 25$16.64Sep 18, 25$18.52Sep 22, 25$17.56Sep 24, 25$17.67Sep 26, 25$17.77Sep 30, 25$17.70Oct 2, 25$18.99Oct 6, 25$19.45Oct 8, 25$19.94Oct 10, 25$17.60Oct 14, 25$17.26Oct 16, 25$17.57Oct 21, 25$18.08Oct 23, 25$17.40Oct 27, 25$17.50Oct 29, 25$17.11Oct 31, 25$16.93Nov 4, 25$16.06Nov 6, 25$15.73Nov 10, 25$15.36Nov 12, 25$15.00Nov 14, 25$14.40Nov 18, 25$13.58Nov 20, 25$12.66Nov 25, 25$13.33Nov 28, 25$13.69Dec 2, 25$12.99Dec 4, 25$13.27Dec 8, 25$13.49Dec 10, 25$14.20Dec 12, 25$14.24Dec 16, 25$14.23Dec 18, 25$14.38Dec 22, 25$15.20Dec 24, 25$14.86Dec 29, 25$14.15Jan 2, 26$13.39Jan 6, 26$14.67Jan 8, 26$14.72Jan 12, 26$14.57Jan 14, 26$14.30Jan 16, 26$14.25Jan 21, 26$14.36Jan 23, 26$15.09Jan 27, 26$14.32Jan 29, 26$13.62Feb 2, 26$13.71Feb 4, 26$15.11Feb 9, 26$24.21Feb 11, 26$25.25Feb 13, 26$23.01Feb 18, 26$25.46Feb 20, 26$21.42Feb 24, 26$18.99Feb 26, 26$19.29Mar 2, 26$18.85Mar 4, 26$18.10Mar 6, 26$18.14Mar 10, 26$19.45Mar 12, 26$21.30Mar 17, 26$22.32Mar 19, 26$22.40Mar 23, 26$20.93Mar 25, 26$22.02Mar 27, 26$20.57Mar 31, 26$21.59Apr 2, 26$23.00Apr 7, 26$19.96Apr 9, 26$19.25Apr 13, 26$18.92Apr 15, 26$19.65Apr 17, 26$23.40Apr 22, 26$24.43Apr 24, 26$23.02Apr 28, 26$21.83Apr 30, 26$21.17May 4, 26$20.03May 6, 26$19.21May 8, 26$19.08May 12, 26$23.30May 14, 26$27.10May 18, 26$25.61May 20, 26$26.09May 22, 26$25.89May 28, 26$24.74Jun 1, 26$24.67Jun 3, 26$24.99Jun 5, 26$25.33Jun 9, 26$25.77Jun 11, 26$26.89Jun 15, 26$25.93Jun 17, 26$25.45Jun 22, 26$25.71Jun 24, 26$25.60Jun 26, 26$28.45Jul 2, 26$27.94
$12.6652-week range$29.24
Loading valuation history…

Fundamentals

Key fundamentals

$1.8B

Market cap

—

Revenue growth (YoY)

-360.0%

Gross margin

-$54.4M

Free cash flow (USD)

-$73.2M

Net debt

Net cash position

15.4%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$0.00FY 2017$0.00FY 2018$0.00FY 2019$0.00FY 2020$0.00FY 2021$1.4MFY 2022$700.0KFY 2023$0.00FY 2024$0.00FY 2025$350.0K
$0$350K

Free cash flow by year

2016 → 2025

FY 2016$-8.1MFY 2017$-13.6MFY 2018$-24.2MFY 2019$-34.8MFY 2020$-35.8MFY 2021$-54.5MFY 2022$-47.4MFY 2023$-33.2MFY 2024$-36.5MFY 2025$-54.4M
-$8.1M-$54.4M

Gross margin by year

2021 → 2025

FY 2021-38.8%FY 2022-1606.3%FY 2025-360.0%
-38.8%-360.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 14, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 12, 2026Filing
  • 8-K eventWarrant Redemption AnnouncementJun 10, 2026Filing
  • Quarterly report10-Q FiledMay 14, 2026Filing
  • 8-K eventEquity Distribution AgreementMay 6, 2026Filing
  • 8-K eventEarnings ReleaseMay 4, 2026Filing
  • Annual report10-K FiledApr 30, 2026Filing
  • 8-K eventClinical Study ResultsApr 27, 2026Filing
  • 8-K eventInvestor Presentation UpdateApr 16, 2026Filing
  • 8-K eventCOO AppointmentApr 9, 2026Filing
  • 8-K eventClinical Study EnrollmentApr 7, 2026Filing

Questions

Frequently asked questions

What is Pulse Biosciences, Inc.'s market cap?

Pulse Biosciences, Inc. (PLSE) has a market capitalization of $1.8B.

What is PLSE's P/E ratio?

A meaningful P/E ratio is not available for PLSE — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is PLSE's price-to-book (P/B) ratio?

PLSE trades at 21.84 times book value per share.

Are insiders buying PLSE stock?

SEC Form 4 filings show no open-market insider buys at Pulse Biosciences, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Instruments & Supplies

NVCR

NovoCure Limited

$2B

NNNN

Anbio Biotechnology Class A Ordinary Shares

$1.5B

STAA

STAAR Surgical Company

$1.5B

XRAY

DENTSPLY SIRONA Inc.

$2.1B

ATRC

AtriCure, Inc.

$1.4B

LMAT

LeMaitre Vascular, Inc.

$2.2B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.